International Journal of Clinical Oncology

, Volume 14, Issue 6, pp 483–484 | Cite as

Sentinel lymph node biopsy in melanoma management: its significance and potential problems

Introduction to Review Articles

Key words

Malignant melanoma Sentinel lymph node biopsy Validity of the concept Significance and problems 


  1. 1.
    Cascinelli N, Morabito A, Santinami M, et al. (1998) Immediate or delayed dissection of regional nodes in patients with melanoma of the trunk: a randomized trial; WHO melanoma programme. Lancet 351:793–796CrossRefPubMedGoogle Scholar
  2. 2.
    Balch CM, Soong S, Ross MI, et al. (2000) Long-term results of a multi-institutional randomized trial comparing prognostic factors and surgical results for intermediate thickness melanomas (1.0 to 4.0 mm): Intergroup Melanoma Surgical Trial. Ann Surg Oncol 7: 87–97CrossRefPubMedGoogle Scholar
  3. 3.
    Ishihara K, Saida T, Otsuka F, et al. (2008) Statistical profiles of malignant melanoma and other skin cancers in Japan: 2007 update. Int J Clin Oncol 13:33–41CrossRefPubMedGoogle Scholar
  4. 4.
    Morton DL, Wen DR, Wong JH, et al. (1992) Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 127:392–399PubMedGoogle Scholar
  5. 5.
    Cochran AJ, Roberts, AA, Saida, T, et al. (2003) The place of lymphatic mapping and sentinel node biopsy in oncology. Int J Clin Oncol 8:139–150CrossRefPubMedGoogle Scholar
  6. 6.
    Medalie N, Ackerman AB (2004) Sentinel node biopsy has no benefit for patients whose primary cutaneous melanoma has metastasized to a lymph node and therefore should be abandoned now. Br J Dermatol 151:298–307CrossRefPubMedGoogle Scholar
  7. 7.
    Fecher LA, Flaherty KT (2009) Where are we with adjuvant therapy of stage III and IV melanoma in 2009? J Natl Compr Canc Netw 7:295–304PubMedGoogle Scholar
  8. 8.
    Morton DL, Thompson JF, Cochran AJ, et al. (2006) Sentinelnode biopsy or nodal observation in melanoma. N Engl J Med 355: 1307–1317CrossRefPubMedGoogle Scholar
  9. 9.
    Russell-Jones R (2005) Sentinel node and survival in melanoma. Br J Dermatol 153:1093–1095CrossRefPubMedGoogle Scholar
  10. 10.
    González U (2007) Cloud over sentinel node biopsy: unlikely survival benefit in melanoma. Arch Dermatol 143:775–776CrossRefPubMedGoogle Scholar
  11. 11.
    Johnson, TM, Sondak, VK, Bichakjian, CK, et al. (2006) The role of sentinel lymph node biopsy for melanoma: evidence assessment. J Am Acad Dermatol 54:19–27CrossRefPubMedGoogle Scholar
  12. 12.
    Cochran AJ, Morton DL, Stern S, et al. (2001) Sentinel lymph nodes show profound downregulation of antigen-presenting cells of the paracortex: implications for tumor biology and treatment. Mod Pathol 14:604–608CrossRefPubMedGoogle Scholar
  13. 13.
    Lee JH, Torisu-Itakara H, Cochran AJ, et al. (2005) Quantitative analysis of melanoma-induced cytokine-mediated immunosuppression in melanoma sentinel nodes. Clin Cancer Res 11: 107–112PubMedGoogle Scholar
  14. 14.
    Balch CM, Buzaid AC, Soong SJ, et al. (2001) Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol 19:3635–3648PubMedGoogle Scholar
  15. 15.
    Moroi Y (2009) Significance of sentinel lymph node biopsy in malignant melanoma: overview of international data. Int J Clin Oncol 14:485–489CrossRefPubMedGoogle Scholar
  16. 16.
    Uhara H, Takata M, Saida T (2009) Sentinel lymph node biopsy in Japan. Int J Clin Oncol 14:490–496CrossRefPubMedGoogle Scholar

Copyright information

© Japan Society of Clinical Oncology 2009

Authors and Affiliations

  1. 1.Department of DermatologyShinshu University School of MedicineMatsumotoJapan

Personalised recommendations